Methods: We conducted a retrospective study including 22 clinical and radiological variables from medical records of patients undergoing MT between April 2016-April 2024
The first one is intrinsic in cancer cells
The defining feature of the BPC-157 sequence is its high proline content
Reported benefits (per available research): Studied in rat full-thickness wound models for accelerating skin repair, with one study reporting reepithelialization increased by up to 61% over controls by day 7, along with greater wound contraction and collagen deposition (Malinda et al., animal study, 1999) Studied in rodent models of ischemic myocardial injury for reducing post-infarct scarring and supporting cardiac tissue repair
for research purposes only Not a controlled substance under the Controlled Substances Act Banned by WADA for athletes under drug-tested competition Often mislabeled or sold as an injectable supplement, which is not legal BPC157 is not approved for medical use and should only be obtained from research peptide suppliers with third-party testing. FDA Guidance on Unapproved Drugs MK677 (Ibutamoren) Not approved by the FDA for therapeutic use Legal for sale as a research chemical Not a controlled substance in the U.S., but flagged by WADA Often mislabeled in the supplement marketoral SARMs containing MK677 are prohibited in sports Popular in anti-aging and bodybuilding clinics , but not prescribable MK677 remains legal to possess and research, but any marketing for human use constitutes an FDA violation. WADA Prohibited List 2024 CJC1295 (with/without DAC) Research-use only compound in the U.S
